Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis

Jalal Soubhye, Ibaa Chikh Alard, Pierre van Antwerpen, François Dufrasne
  • Future Medicinal Chemistry, August 2015, Future Science
  • DOI: 10.4155/fmc.15.74
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Jalal Soubhye